Name | Number of supported studies | Average coverage | |
---|---|---|---|
monocyte | 19 studies | 36% ± 19% | |
fibroblast | 19 studies | 32% ± 13% | |
classical monocyte | 18 studies | 39% ± 18% | |
macrophage | 15 studies | 27% ± 12% | |
dendritic cell | 14 studies | 32% ± 13% | |
non-classical monocyte | 13 studies | 39% ± 17% | |
conventional dendritic cell | 13 studies | 25% ± 7% | |
neutrophil | 12 studies | 63% ± 17% | |
adipocyte | 10 studies | 58% ± 24% | |
myeloid cell | 9 studies | 30% ± 13% | |
pericyte | 7 studies | 22% ± 6% | |
basal cell | 7 studies | 21% ± 7% | |
kidney loop of Henle epithelial cell | 5 studies | 22% ± 5% | |
renal alpha-intercalated cell | 5 studies | 37% ± 3% | |
epithelial cell | 5 studies | 39% ± 20% | |
mononuclear phagocyte | 4 studies | 43% ± 21% | |
endothelial cell | 4 studies | 21% ± 4% | |
ciliated cell | 4 studies | 33% ± 12% | |
endothelial cell of vascular tree | 4 studies | 34% ± 19% | |
epithelial cell of proximal tubule | 3 studies | 20% ± 3% | |
intermediate monocyte | 3 studies | 36% ± 1% | |
monocyte-derived dendritic cell | 3 studies | 56% ± 16% | |
secretory cell | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 97% | 12467.48 | 219 / 226 | 90% | 253.60 | 365 / 406 |
kidney | 98% | 6002.73 | 87 / 89 | 85% | 103.02 | 762 / 901 |
lung | 91% | 10470.47 | 524 / 578 | 82% | 86.53 | 949 / 1155 |
adrenal gland | 99% | 6839.08 | 256 / 258 | 69% | 81.51 | 159 / 230 |
breast | 82% | 18181.47 | 376 / 459 | 57% | 50.83 | 633 / 1118 |
stomach | 57% | 1549.01 | 206 / 359 | 81% | 61.22 | 232 / 286 |
ovary | 67% | 1442.58 | 120 / 180 | 62% | 25.34 | 265 / 430 |
adipose | 99% | 27086.80 | 1196 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 10% | 299.88 | 34 / 328 | 88% | 113.02 | 157 / 178 |
bladder | 29% | 1219.05 | 6 / 21 | 67% | 75.41 | 337 / 504 |
intestine | 13% | 441.81 | 121 / 966 | 76% | 54.82 | 400 / 527 |
lymph node | 0% | 0 | 0 / 0 | 86% | 116.97 | 25 / 29 |
heart | 86% | 3712.95 | 737 / 861 | 0% | 0 | 0 / 0 |
thymus | 17% | 626.63 | 112 / 653 | 65% | 74.76 | 392 / 605 |
uterus | 4% | 83.73 | 7 / 170 | 75% | 99.81 | 344 / 459 |
prostate | 31% | 1003.02 | 76 / 245 | 43% | 12.51 | 217 / 502 |
muscle | 65% | 4205.72 | 518 / 803 | 0% | 0 | 0 / 0 |
esophagus | 8% | 226.92 | 119 / 1445 | 55% | 35.57 | 100 / 183 |
skin | 21% | 579.39 | 372 / 1809 | 35% | 32.13 | 166 / 472 |
spleen | 51% | 1474.54 | 124 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 49% | 6412.62 | 451 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 47% | 25.74 | 21 / 45 |
brain | 3% | 44.95 | 67 / 2642 | 27% | 14.76 | 189 / 705 |
blood vessel | 24% | 1530.80 | 324 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_2001238 | Biological process | positive regulation of extrinsic apoptotic signaling pathway |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0005811 | Cellular component | lipid droplet |
GO_0005739 | Cellular component | mitochondrion |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | G0S2 |
Protein name | G0/G1 switch protein 2 (G0/G1 switch regulatory protein 2) (Putative lymphocyte G0/G1 switch gene) |
Synonyms | |
Description | FUNCTION: Promotes apoptosis by binding to BCL2, hence preventing the formation of protective BCL2-BAX heterodimers. . |
Accessions | ENST00000367029.5 P27469 |